Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Nashville,, TN
SEC filing record 1 source field available
Fiscal year end
31 December
CUMBERLAND PHARMACEUTICALS INC has filed 1,032 SEC EDGAR filings since 02 May 2002

SEC filing history

Showing 51-75 of 959 matching filings.

Per page
25
Current page
3
4

FORM 4

Filing date
12 Sep 2025
Reporting date
01 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Sep 2025
Reporting date
01 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Sep 2025
Reporting date
01 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 001-33637

UPLOAD filing

Filing date
25 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
15 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Aug 2025
Reporting date
01 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Aug 2025
Reporting date
01 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Aug 2025
Reporting date
01 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Aug 2025
Reporting date
01 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 001-33637

UPLOAD filing

Filing date
04 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jul 2025
Reporting date
02 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jul 2025
Reporting date
02 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jul 2025
Reporting date
02 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jul 2025
Reporting date
02 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jun 2025
Reporting date
01 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jun 2025
Reporting date
01 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jun 2025
Reporting date
01 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jun 2025
Reporting date
01 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-85205

SCHEDULE 13G filing

Filing date
15 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 May 2025
Reporting date
01 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 May 2025
Reporting date
01 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 May 2025
Reporting date
01 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 May 2025
Reporting date
01 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .